B Olsen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B Olsen

Showing results (661-670 of 665) with videos related to

Pageof 67

Sort By:

You have reached the last page of results.This site can display upto 665 results.

Ebiomedicine|December 7, 2025

MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.

Nature Methods|June 30, 2015

Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitationEdyta Marcon, Harshika Jain, Anandi Bhattacharya, et al.

ACS Infectious Diseases|February 22, 2022

Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.

Cancer Immunology Research|June 12, 2025

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.

Journal of Medicinal Chemistry|February 16, 2024

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.

Pageof 67

Search research articles

Showing results (661-670 of 665) with videos related to

Sort By:

Pageof 67

You have reached the last page of results.This site can display upto 665 results.

Ebiomedicine|December 7, 2025

MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.

Nature Methods|June 30, 2015

Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitationEdyta Marcon, Harshika Jain, Anandi Bhattacharya, et al.

ACS Infectious Diseases|February 22, 2022

Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.

Cancer Immunology Research|June 12, 2025

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.

Journal of Medicinal Chemistry|February 16, 2024

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.

Pageof 67